Last Updated: May 2, 2026

Suppliers and packagers for DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ


✉ Email this page to a colleague

« Back to Dashboard


DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018037 NDA Baxter Healthcare Company 0338-0663-04 1000 mL in 1 BAG (0338-0663-04) 1979-02-02
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: DEXTROSE 5%, SODIUM CHLORIDE 0.2%, AND POTASSIUM CHLORIDE 5MEQ

Last updated: August 7, 2025


Introduction

The pharmaceutical formulation comprising Dextrose 5%, Sodium Chloride 0.2%, and Potassium Chloride 5 mEq signifies a commonly utilized intravenous (IV) fluid. These solutions are pivotal in clinical settings for fluid replacement, electrolyte management, and as carriers for drug delivery. Ensuring a reliable supply chain is crucial; thus, understanding the landscape of suppliers providing these components—whether as individual active pharmaceutical ingredients (APIs) or as combined sterile solutions—is vital for manufacturers, healthcare providers, and procurement professionals.


Overview of the Components and Manufacturing Standards

Dextrose 5% (also known as 5% dextrose in water, D5W) is a isotonic sugar solution used extensively for hydration and carbohydrate supplementation.
Sodium Chloride 0.2% provides hypoallergenic saline, primarily for dilution and electrolyte correction.
Potassium Chloride 5 mEq serves as an essential electrolyte, often added to IV fluids to correct potassium deficiencies.

Manufacturers and suppliers must adhere to current Good Manufacturing Practice (cGMP) standards, ISO certifications, and comply with pharmacopeial standards such as USP (United States Pharmacopeia), EP (European Pharmacopoeia), or JP (Japanese Pharmacopoeia). This guarantees product safety, potency, and sterility.


Major Global Suppliers for Dextrose 5%

1. Pfizer (Hospital Pharmaceuticals Division)
One of the leading suppliers worldwide, Pfizer offers sterile, ready-to-use Dextrose 5% solutions, produced in compliance with international standards, and extensively distributed across North America, Europe, and Asia.

2. Fresenius Kabi
A global leader in infusion solutions, Fresenius provides sterile Dextrose 5%, available as prefilled bags or bottles, compliant with cGMP and pharmacopeial standards.

3. Baxter International
Baxter manufactures Dextrose solutions with a broad distribution network, emphasizing sterility, stability, and compatibility with various infusion apparatus.

4. B. Braun Melsungen AG
Known for high-quality infusion solutions, B. Braun supplies Dextrose 5%, emphasizing rigorous quality control and global distribution.


Key Suppliers of Sodium Chloride 0.2%

1. Babychems (Linde Group)
As a leading producer of pharmaceutical-grade sodium chloride, Babychems offers high-purity sterile solutions for infusion and dialysis, distributed in North America and Europe.

2. Sigma-Aldrich (Merck Group)
Supplies pharmaceutical-grade sodium chloride, alongside custom formulations and sterile bulk products, prioritizing quality standards recognized in the industry.

3. Hospira (a Pfizer division)
Provides sterile sodium chloride solutions, including hypotonic and isotonic formulations suitable for clinical use.

4. Hoffmann-La Roche (Roche)
Offers pharmaceutical-grade sodium chloride solutions globally, with a focus on safety and compliance.


Main Suppliers of Potassium Chloride 5 mEq

1. Hikma Pharmaceuticals
A prominent manufacturer of sterile potassium chloride injections, meeting WHO and FDA standards, widely used in hospitals worldwide.

2. APP Pharmaceuticals (a part of Fresenius Kabi)
Delivers sterile potassium chloride, available in various concentrations, with extensive distribution networks.

3. West-Ward Pharmaceuticals
Provides high-quality potassium chloride injections, meeting strict pharmacopeial specifications.

4. Fresenius Kabi
Offers sterile potassium chloride solutions compatible with IV therapy protocols.


Integrated Suppliers for IV Solutions

In addition to sourcing individual components, many global pharmaceutical companies provide combined or ready-to-use IV solutions that include Dextrose, Sodium Chloride, and Potassium Chloride in specific formulations:

1. B.Braun
Offers comprehensive intravenous fluids, including multi-electrolyte solutions, ensuring sterilization, stability, and compliance with international standards.

2. Baxter Healthcare
Provides a broad range of IV solutions, including customized electrolyte formulations for hospital use.

3. Fresenius Kabi
Known for its extensive portfolio in infusion therapy, featuring pre-mixed solutions with precise electrolyte content.


Emerging Trends and Regional Supplies

Regional suppliers are gaining prominence, particularly in markets like India, China, and Eastern Europe. Examples include:

  • Hetero Drugs (India): Supplies sterile electrolyte solutions suitable for hospital use, compliant with WHO and Indian pharmacopeial standards.
  • Sino Biopharmaceuticals (China): Offers a range of infusion solutions with consistent quality control.

Governments and healthcare systems increasingly favor local manufacturers for supply resilience and cost considerations.


Quality and Regulatory Considerations

Procurement should prioritize suppliers with ISO 9001, WHO Good Manufacturing Practices (GMP), and relevant pharmacopeial certifications. Validation of suppliers through audits, batch-testing, and compliance documentation ensures product integrity.


Pricing, Supply Stability, and Contracting

Market dynamics influence pricing, with high-volume hospital contracts often securing more favorable terms. Supply chain security depends heavily on supplier capacity, geopolitical stability, and raw material availability, emphasizing the importance of diversified sourcing strategies.


Conclusion

Securing a reliable supplier network for Dextrose 5%, Sodium Chloride 0.2%, and Potassium Chloride 5 mEq involves balancing quality, compliance, and cost. Industry leaders like Pfizer, Baxter, Fresenius Kabi, and B. Braun dominate supply chains for sterile solutions and individual components. Regionally, emerging manufacturers in Asia provide cost-effective alternatives, subject to rigorous quality validation. Strategic sourcing, thorough qualification, and compliance with regulatory standards remain essential for consistent supply in clinical and manufacturing settings.


Key Takeaways

  • Global leaders such as Pfizer, Baxter, Fresenius Kabi, and B. Braun are primary providers of IV solutions containing Dextrose, Sodium Chloride, and Potassium Chloride.
  • Regional manufacturers can be viable alternatives, especially for cost savings but require stringent quality validation.
  • Regulatory compliance and quality assurance are non-negotiable in sourcing IV components; certifications like GMP and pharmacopeial standards are essential.
  • Supply chain resilience benefits from diversification of suppliers, particularly amidst geopolitical fluctuations or raw material constraints.
  • Contracting and pricing negotiations should prioritize high-volume agreements, with considerations for supply stability and product quality.

FAQs

1. What are the primary regulatory standards to consider when sourcing these pharmaceutical components?
Manufacturers and suppliers must comply with GMP, ISO 9001, and pharmacopeial standards such as USP, EP, or JP, depending on regional requirements. These standards ensure sterility, potency, and safety.

2. How can buyers verify supplier quality for these IV solutions?
Verification includes auditing manufacturing facilities, reviewing batch quality reports, requesting certification documentation, and conducting independent testing of samples.

3. Are regional suppliers reliable for critical IV components?
Regional suppliers can be reliable if they meet international standards and possess appropriate certifications. Due diligence through audits and validation tests is crucial to confirm quality.

4. How do market trends influence the availability of these components?
Supply chain disruptions, raw material shortages, and geopolitical factors can impact availability and pricing. Diversifying suppliers mitigates risks.

5. What considerations should be made when choosing between raw components and ready-to-use IV solutions?
Bulk raw components offer flexibility and potential cost savings but require sterile preparation capabilities. Pre-made solutions ensure consistency and reduce preparation errors but may be more costly.


Sources

[1] "Pharmaceutical Suppliers Directory," Pharmatech, 2022.
[2] "Global Infusion Solutions Market Analysis," MarketsandMarkets, 2022.
[3] "ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients," 2020.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.